Michael Cooreman - Publications, H-index & Citations

Michael Cooreman

inventiva pharma

16H指数

47论文数

1.2K被引数

收录论文 13

发表时间

Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis 兰尼非布洛尔治疗代谢功能障碍相关脂肪性肝炎患者组织学反应的生物标志物

Clinical Gastroenterology and Hepatology

IF12

2025-03-17

PREAI

Jérôme Boursier; Hugo Hervé; Marine Roux; Manal F. Abdelmalek; Sven M. Francque; Pierre Broqua; Jean-Louis Junien; Jean-Louis Abitbol; Philippe Huot-Marchand; Lucile Dzen; Michael P. Cooreman; Sanjaykumar Patel

Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics 细胞外基质相关诊断和治疗的研究进展

JOURNAL OF CLINICAL MEDICINE

IF2.9

2025-03-10

OAAI

Karsdal, Morten; Cox, Thomas R.; Parker, Amelia L.; Willumsen, Nicholas; Sand, Jannie Marie Buelow; Jenkins, Gisli; Hansen, Henrik H.; Oldenburger, Anouk; Geillinger-Kaestle, Kerstin E.; Larsen, Anna Thorso; Black, Darcey; Genovese, Federica; Eckersley, Alexander; Heinz, Andrea; Nystroem, Alexander; Holm Nielsen, Signe; Bennink, Lucas; Johannsson, Lars; Bay-Jensen, Anne-Christine; Orange, Dana E.; Friedman, Scott; Ropke, Mads; Fiore, Vincent; Schuppan, Detlef; Rieder, Florian; Simona, Benjamin; Borthwick, Lee; Skarsfeldt, Mark; Wennbo, Haakan; Thakker, Paresh; Stoffel, Ruedi; Clarke, Graham W.; Kalluri, Raghu; Ruane, Darren; Zannad, Faiez; Mortensen, Joachim Hog; Sinkeviciute, Dovile; Sundberg, Fred; Coseno, Molly; Thudium, Christian; Croft, Adam P.; Khanna, Dinesh; Cooreman, Michael; Broermann, Andre; Leeming, Diana Julie; Mobasheri, Ali; Ricard-Blum, Sylvie

MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2024-06-01

PREAI

Cooreman, Michael P.; Vonghia, Luisa; Francque, Sven M.

The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis Pan-ppar激动剂lanifbranor改善代谢功能障碍相关脂肪性肝炎患者的心脏代谢健康

NATURE COMMUNICATIONS

IF15.7

2024-05-10

OAAI

Cooreman, Michael P.; Butler, Javed; Giugliano, Robert P.; Zannad, Faiez; Dzen, Lucile; Huot-Marchand, Philippe; Baudin, Martine; Beard, Daniel R.; Junien, Jean-Louis; Broqua, Pierre; Abdelmalek, Manal F.; Francque, Sven M.

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

EBIOMEDICINE

IF10.8

2017-12-01

OAAI

Daveson, A. James M.; Ee, Hooi C.; Andrews, Jane M.; King, Timothy; Goldstein, Kaela E.; Dzuris, John L.; MacDougall, James A.; Williams, Leslie J.; Treohan, Anita; Cooreman, Michael P.; Anderson, Robert P.

The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis

GASTROENTEROLOGY

IF25.1

2014-08-01

OAAI

Manns, Michael P.; Vierling, John M.; Bacon, Bruce R.; Bruno, Savino; Shibolet, Oren; Baruch, Yaacov; Marcellin, Patrick; Caro, Luzelena; Howe, Anita Y. M.; Fandozzi, Christine; Gress, Jacqueline; Gilbert, Christopher L.; Shaw, Peter M.; Cooreman, Michael P.; Robertson, Michael N.; Hwang, Peggy; Dutko, Frank J.; Wahl, Janice; Mobashery, Niloufar

NON-ALCOHOLIC STEATOHEPATITIS CLINICAL DEVELOPMENT: AN OPPORTUNITY FOR NON-INVASIVE SERUM OR IMAGING BIOMARKERS FROM A COST-EFFICIENCY PERSPECTIVE

VALUE IN HEALTH

IF6

2014-05-01

OAAI

Agnese, W.; Suciu, S.; Liu, S.; Sood, V; Cooreman, M.

RELATIONSHIP BETWEEN TRANSAMINASE LEVELS AND PLASMA PHARMACOKINETICS FOLLOWING ADMINISTRATION OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) TO HCV GENOTYPE (G) 1 TREATMENT-NAIVE PATIENTS

JOURNAL OF HEPATOLOGY

IF33

2013-04-01

OAAI

Caro, L.; Du, L.; Huang, S.; Wenning, L.; Su, J.; Hwang, P. M. T.; Valesky, R.; Gilbert, C.; Gress, J.; Klaassen, F.; Gendrano, I. N.; Brunhofer, J.; Cooreman, M.; Huisman, J.; Mobashery, N.

HIGH SUSTAINED VIRAL RESPONSE AT 12-AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

JOURNAL OF HEPATOLOGY

IF33

2013-04-01

PREAI

Manns, M.; Vierling, J. M.; Bacon, B. R.; Marcellin, P.; Caro, L.; Gress, J.; Gilbert, C.; Cooreman, M. P.; Robertson, M.; Hwang, P.; Wahl, J.; Mobashery, N.

DIRECT INHIBITION OF NS3/4A WITH BOCEPREVIR DOES NOT INCREASE INDUCTION OF ISG: AN ANALYSIS OF THE PIVOTAL BOCEPREVIR TRIALS (SPRINT-2/RESPOND-2)

JOURNAL OF HEPATOLOGY

IF33

2012-04-01

PREAI

Molony, C.; Cristescu, R.; Shaw, P.; Shire, N.; Wahl, J.; Brass, C.; Cooreman, M.

Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2010-05-10

101

OAAI

Toombs, Christopher F.; Insko, Michael A.; Wintner, Edward A.; Deckwerth, Thomas L.; Usansky, Helen; Jamil, Khurram; Goldstein, Brahm; Cooreman, Michael; Szabo, Csaba

NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2006-09-01

179

OAAI

Ma, Sue; Boerner, Joanna E.; TiongYip, ChoiLai; Weidmann, Beat; Ryder, Neil S.; Cooreman, Michael P.; Lin, Kai

KLF6 promotes adipocyte differentiation through histone deacetylase 3 (HDAC3)-dependent repression of Dlk1

GASTROENTEROLOGY

IF25.1

2003-04-01

OAAI

Li, D; Yea, S; Laborda, J; Cooreman, M; Narla, G; Eng, FJ; Walsh, MJ; Friedman, SL

研究方向